Konrad E. Tomaszewski

1.0k total citations
18 papers, 753 citations indexed

About

Konrad E. Tomaszewski is a scholar working on Infectious Diseases, Clinical Biochemistry and Molecular Biology. According to data from OpenAlex, Konrad E. Tomaszewski has authored 18 papers receiving a total of 753 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 5 papers in Clinical Biochemistry and 4 papers in Molecular Biology. Recurrent topics in Konrad E. Tomaszewski's work include Metabolism and Genetic Disorders (5 papers), Antifungal resistance and susceptibility (4 papers) and Peroxisome Proliferator-Activated Receptors (4 papers). Konrad E. Tomaszewski is often cited by papers focused on Metabolism and Genetic Disorders (5 papers), Antifungal resistance and susceptibility (4 papers) and Peroxisome Proliferator-Activated Receptors (4 papers). Konrad E. Tomaszewski collaborates with scholars based in United States, United Kingdom and Germany. Konrad E. Tomaszewski's co-authors include Nolan Wood, Ronald L. Melnick, Bharat Damle, David R. Luke, Haran T. Schlamm, Keith Tan, Peter F. Troke, Deepak Agarwal, Michael J. Olson and Daniel S. Marsman and has published in prestigious journals such as Journal of Pharmaceutical Sciences, Carcinogenesis and Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.

In The Last Decade

Konrad E. Tomaszewski

17 papers receiving 728 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Konrad E. Tomaszewski United States 11 342 225 216 108 92 18 753
Satoshi Kishino Japan 16 232 0.7× 197 0.9× 176 0.8× 127 1.2× 91 1.0× 56 711
Martin Béliveau United States 18 146 0.4× 180 0.8× 95 0.4× 51 0.5× 61 0.7× 29 942
Souzan B. Yanni United States 8 153 0.4× 58 0.3× 90 0.4× 75 0.7× 119 1.3× 12 402
Dan K. Chalker United States 13 75 0.2× 247 1.1× 116 0.5× 49 0.5× 74 0.8× 23 1.4k
F A deLuna United States 15 218 0.6× 164 0.7× 108 0.5× 130 1.2× 292 3.2× 24 844
Evan W. McChesney United States 19 160 0.5× 224 1.0× 62 0.3× 253 2.3× 97 1.1× 48 1.1k
Sudhakar M. Pai United States 12 248 0.7× 48 0.2× 184 0.9× 83 0.8× 71 0.8× 31 600
James P. Sams United States 12 204 0.6× 368 1.6× 51 0.2× 212 2.0× 247 2.7× 17 817
Alison E. Aitken United States 6 98 0.3× 160 0.7× 97 0.4× 105 1.0× 234 2.5× 6 767
Nasrin Amiri‐Dashatan Iran 13 120 0.4× 257 1.1× 136 0.6× 36 0.3× 37 0.4× 43 743

Countries citing papers authored by Konrad E. Tomaszewski

Since Specialization
Citations

This map shows the geographic impact of Konrad E. Tomaszewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Konrad E. Tomaszewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Konrad E. Tomaszewski more than expected).

Fields of papers citing papers by Konrad E. Tomaszewski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Konrad E. Tomaszewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Konrad E. Tomaszewski. The network helps show where Konrad E. Tomaszewski may publish in the future.

Co-authorship network of co-authors of Konrad E. Tomaszewski

This figure shows the co-authorship network connecting the top 25 collaborators of Konrad E. Tomaszewski. A scholar is included among the top collaborators of Konrad E. Tomaszewski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Konrad E. Tomaszewski. Konrad E. Tomaszewski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Zrenner, Eberhart, et al.. (2014). Effects of Multiple Doses of Voriconazole on the Vision of Healthy Volunteers: A Double-Blind, Placebo-Controlled Study. Ophthalmic Research. 52(1). 43–52. 23 indexed citations
2.
Luke, David R., Nolan Wood, Konrad E. Tomaszewski, & Bharat Damle. (2011). Pharmacokinetics of sulfobutylether- -cyclodextrin (SBECD) in subjects on hemodialysis. Nephrology Dialysis Transplantation. 27(3). 1207–1212. 40 indexed citations
3.
Luke, David R., Konrad E. Tomaszewski, Bharat Damle, & Haran T. Schlamm. (2010). Review of the Basic and Clinical Pharmacology of Sulfobutylether-β-Cydodextrin (SBECD). Journal of Pharmaceutical Sciences. 99(8). 3291–3301. 164 indexed citations
4.
Laties, Alan M., Frederick T. Fraunfelder, Konrad E. Tomaszewski, et al.. (2010). Long-term visual safety of voriconazole in adult patients with paracoccidioidomycosis. Clinical Therapeutics. 32(13). 2207–2217. 7 indexed citations
5.
Abel, Sylvie, Richard Allan, Kuan Gandelman, et al.. (2008). Pharmacokinetics, Safety and Tolerance of Voriconazole in Renally??Impaired Subjects. Clinical Drug Investigation. 28(7). 409–420. 42 indexed citations
6.
Ayoub, Ashraf, James Goodrich, Randall Tressler, et al.. (2008). Incidence of infections in treatment-experienced (TE) patients in the MOTIVATE studies of maraviroc (MVC) plus optimized background therapy (OBT). Journal of the International AIDS Society. 11(Suppl 1). P154–P154. 1 indexed citations
7.
Tan, Keith, et al.. (2006). Investigation of the Potential Relationships Between Plasma Voriconazole Concentrations and Visual Adverse Events or Liver Function Test Abnormalities. The Journal of Clinical Pharmacology. 46(2). 235–243. 198 indexed citations
8.
Tomaszewski, Konrad E. & Ronald L. Melnick. (1994). In vitro evidence for involvement of CoA thioesters in peroxisome proliferation and hypolipidaemia. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1220(2). 118–124. 10 indexed citations
9.
Net, Jean-Loïc Le, et al.. (1993). An investigation of Urinary Creatine Excretion as a Potential Marker for Testicular Damage. Human & Experimental Toxicology. 12(2). 173–176. 7 indexed citations
10.
Tomaszewski, Konrad E.. (1993). Application of Animal Toxicology Data to Clinical Study of Experimental Drugs. Comparative Clinical Pathology. 3(2). 67–70. 2 indexed citations
11.
Tomaszewski, Konrad E., et al.. (1991). The production of hepatic cirrhosis in rats. Journal of Applied Toxicology. 11(3). 229–231. 5 indexed citations
12.
Tomaszewski, Konrad E., et al.. (1990). Induction of peroxisomal acyl CoA oxidase activity and lipid peroxidation in primary rat hepatocyte cultures. Toxicology. 65(1-2). 49–60. 23 indexed citations
13.
Conway, James G., Konrad E. Tomaszewski, Michael J. Olson, et al.. (1989). Relationship of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and Wy-14,643. Carcinogenesis. 10(3). 513–519. 101 indexed citations
14.
Tomaszewski, Konrad E., Charles A. Montgomery, & Ronald L. Melnick. (1988). Modulation of 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity in F344 rats by di(2-ethylhexyl)phthalate. Chemico-Biological Interactions. 65(3). 205–222. 17 indexed citations
15.
Tomaszewski, Konrad E., et al.. (1987). A biochemical basis for 1,2-dibromo-3-chloropropane-induced male infertility: Inhibition of sperm mitochondrial electron transport activity. Toxicology and Applied Pharmacology. 91(2). 274–280. 6 indexed citations
16.
Melnick, Ronald L., Richard E. Morrissey, & Konrad E. Tomaszewski. (1987). Studies By the National Toxicology Program On Di(2-Ethylhexyl)Phthalate. Toxicology and Industrial Health. 3(2). 99–118. 23 indexed citations
17.
Tomaszewski, Konrad E., et al.. (1987). Acyl CoA oxidase is the most suitable marker for hepatic peroxisomal changes caused by treatment of F344 rats with Di(2-ethylhexyl)phthalate. Toxicology Letters. 37(3). 203–212. 19 indexed citations
18.
Tomaszewski, Konrad E., Deepak Agarwal, & Ronald L. Melnick. (1986). In vitro steady-state levels of hydrogen peroxide after exposure of male F344 rats and female B6C3F1 mice to hepatic peroxisome proliferators. Carcinogenesis. 7(11). 1871–1876. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Satoshi Kishino Breakdown of academic impact, for papers by Martin Béliveau Breakdown of academic impact, for papers by Souzan B. Yanni Breakdown of academic impact, for papers by Dan K. Chalker Breakdown of academic impact, for papers by F A deLuna Breakdown of academic impact, for papers by Evan W. McChesney Breakdown of academic impact, for papers by Sudhakar M. Pai Breakdown of academic impact, for papers by James P. Sams Breakdown of academic impact, for papers by Alison E. Aitken Breakdown of academic impact, for papers by Nasrin Amiri‐Dashatan
Rankless by CCL
2026